Clinical trials: Scleroderma (Limited and Diffuse), open to volunteers
- Condition Scleroderma (Limited and Diffuse)
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Systemic Sclerosis
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
The main purpose of the study is to investigate the efficacy on cutaneous thickness and the safety of Nemolizumab in adult patients with systemic sclerosis after a 52-week treatment period and to select the optimal dose for this…
- Trial name
- NCT07047690
- Testing
- Nemolizumab
- Where
- 3 sites in United States, Switzerland
- Volunteers
- 162 people
- Sponsor
- Galderma R&D